Cannabis
Our work in Cannabis
-
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients
Schaeffer experts estimate the primary care prevalence of medical cannabis use according to confidential patient survey and to compare the prevalence of medical cannabis use documented in the EHR with patient report.
-
Trends in the Use of Cannabis Products in Canada and the USA, 2018 – 2020: Findings From the International Cannabis Policy Study
There is little information on consumption patterns across the diverse range of cannabis product types. This paper examines trends in consumption patterns in Canada and the United States (US) between 2018-2020.
-
Impact of Cannabis Legalization on Healthcare Utilization for Psychosis and Schizophrenia in Colorado
Using administrative data from Colorado Hospital Association (CHA) on county-level quarterly ED visits between January 1, 2013, and December 31, 2018, Schaeffer experts applied a difference-in-difference analysis to examine how new exposure to recreational cannabis dispensaries after 2014 differentially influenced the rate of ED visits for psychosis and schizophrenia, comparing counties with no prior medical cannabis dispensary exposure to counties with low or high medical dispensary exposure.
-
Schaeffer Expert Warns of Lax Regulation of U.S. Cannabis Market at U.N. Event
Rosalie Liccardo Pacula presented findings at the U.N. Commission on Narcotic Drugs side event.
-
Cannabis Legalization and Cannabis-Involved Pregnancy Hospitalizations in Colorado
The primary objective of this study was to evaluate the association between presence of recreational cannabis dispensaries and prevalence of cannabis-involved pregnancy hospitalizations in Colorado.
-
Comparison of Hospital Claims and Poison Center Data to Evaluate Health Impact of Opioids, Cannabis and Synthetic Cannabinoids
Schaeffer Center experts compare hospital claims data (Colorado Hospital Association (CHA)) and poison center cases to describe opioid, cannabis and synthetic cannabinoid-related healthcare encounters and exposures in Colorado from 2013 to 2017.
-
Cannabis Flower Prices and Transitions to Legal Sources After Legalization in Canada, 2019–2020
Schaeffer experts analyze if consumers in Canada are purchasing through the legal market or still purchasing from other sources.
-
Trends in Cannabis Involvement and Risk of Alcohol Involvement in Motor Vehicle Crash Fatalities in the United States, 2000‒2018
This study assesses To assess cannabis and alcohol involvement among motor vehicle crash (MVC) fatalities in the United States.
-
Changes in Emergency Department Encounters for Vomiting After Cannabis Legalization in Colorado
Cannabis hyperemesis syndrome is an emerging clinical issue associated with cannabis use. Legalization of cannabis has led to an increase in vomiting-related illnesses in health care settings.
-
Kids and Cannabis: California Dispensaries Lack Adequate Screening to Keep Out Minors, USC-UCSD study finds
The study of 700 licensed cannabis dispensaries found many retail locations have inadequate screening processes.